BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3332008)

  • 1. Chromosomal translocations in B-cell derived tumors.
    Klein G
    Princess Takamatsu Symp; 1986; 17():159-70. PubMed ID: 3332008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned tumorigenicity of activated oncogenes.
    Klein G; Klein E
    Cancer Res; 1986 Jul; 46(7):3211-24. PubMed ID: 3011242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
    Klein G
    Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forward and reverse changes in Ig/myc translocation carrying tumors.
    Klein G
    Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
    Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
    Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
    EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
    Rätsch A; Joos S; Kioschis P; Lichter P
    Exp Cell Res; 2002 Feb; 273(1):12-20. PubMed ID: 11795942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc translocations in B cell and plasma cell neoplasms.
    Janz S
    DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocations among antibody genes in human cancer.
    Leder P
    IARC Sci Publ; 1985; (60):341-57. PubMed ID: 4065947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S; Babonits M; Klein G
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of B-cell derived tumors in humans and rodents.
    Klein G
    Princess Takamatsu Symp; 1988; 19():3-13. PubMed ID: 2855874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc.
    Boffa LC; Cutrona G; Cilli M; Matis S; Damonte G; Mariani MR; Millo E; Moroni M; Roncella S; Fedeli F; Ferrarini M
    Cancer Gene Ther; 2007 Feb; 14(2):220-6. PubMed ID: 17053816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.
    Jain R; Roncella S; Hashimoto S; Carbone A; Francia di Celle P; Foa R; Ferrarini M; Chiorazzi N
    J Immunol; 1994 Jul; 153(1):45-52. PubMed ID: 8207254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6:7) chromosomal translocation.
    Sümegi J; Spira J; Bazin H; Szpirer J; Levan G; Klein G
    Nature; 1983 Dec 1-7; 306(5942):497-8. PubMed ID: 6646229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.